Editor's Note: According to the FDA Web site, on Nov. 29, 2005, the FDA's Center for Drug Evaluation and Research (CDER) rescinded the Nov. 18, 2005, approval of Kali Laboratories' ANDA 76-506 for ...
Jan. 4, 2006 — The US Food and Drug Administration (FDA) approved in November 2005 first-time generic formulations of promethazine HCl 12.5-, 25-, and 50-mg tablets for approved indications in ...
* Ofloxacin otic solution began shipping to customers on august 1, 2016 and will be available at most major retailers across u.s. * Ofloxacin otic solution began shipping to customers on august 1, ...
BARCELONA, Spain--(BUSINESS WIRE)--SALVAT announced today the submission of the response to the FDA Approvable Letter for CETRAXAL® (Ciprofloxacin 0.2% Otic Solution in Single Dose Containers). In an ...
Taro Pharmaceuticals recalled two lots of prescription medicine used for ear infections Wednesday after testing found a problem with an impurity and another with cortisone volume, according to an FDA ...
Laboratorios SALVAT S.A. and Arbor announced the launch of Otovel (ciprofloxacin and fluocinolone) otic solution, the first antibiotic and steroid combination ear drop available in sterile, ...
BOSTON, Mass., IRVINE, Calif., & REHOVOT, Israel--(BUSINESS WIRE)--Tokai Pharmaceuticals Inc. (NASDAQ:TKAI) and Otic Pharma Ltd., a privately-held, clinical-stage pharmaceutical company focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback